Tarsometatarsal joints

From WikiMD's Medical Encyclopedia

Tarsometatarsal joints (also known as Lisfranc joints) are the articulations in the foot between the tarsal bones and the metatarsal bones. They are named after Jacques Lisfranc de St. Martin, a French surgeon and gynecologist who first described the injury to these joints in 1815.

Etymology[edit]

The term "Lisfranc" is derived from the name of Jacques Lisfranc de St. Martin, a French surgeon and gynecologist. He was the first to describe the injury to these joints in 1815 during the Napoleonic Wars. He noted that cavalrymen who fell from their horses but kept their foot caught in the stirrup often sustained this type of injury.

Anatomy[edit]

The tarsometatarsal joints are complex and consist of three types of joints: the first is a synovial joint between the first metatarsal and the medial cuneiform, the second is a synovial joint between the second metatarsal and the middle cuneiform, and the third is a synovial joint between the third, fourth, and fifth metatarsals and the lateral cuneiform and the cuboid.

Function[edit]

The tarsometatarsal joints play a crucial role in the normal function of the foot. They allow for the necessary movements of the foot, including flexion, extension, abduction, adduction, and some rotation. These movements are essential for walking, running, and jumping.

Clinical significance[edit]

Injuries to the tarsometatarsal joints, known as Lisfranc injuries, can be severe and often require surgical intervention. They can occur due to direct trauma, such as a heavy object falling on the foot, or indirect trauma, such as the foot twisting during a fall. These injuries can lead to long-term complications, including chronic pain, arthritis, and difficulty walking.

See also[edit]

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.